ListedMainboard

Sahajanand Medical Technologies IPO Subscription Status

Bidding day 3 · Bidding closed 19 Oct 2026 · Last checked 31 Oct 2026, 9:00 am IST

CategorySubscription
QIB34.7x
NII14.64x
Retail (RII)3.04x
Total14.21x

Day-wise subscription

DayQIBsNIIbNIIRetailEmployeeTotal
Day 334.7x——3.04x—14.21x

Times subscribed per category (bids vs shares offered, anchor portion excluded). Bidding has closed — these are the final figures.

How the book filled

Day-by-day demand

Our day-wise record for the Sahajanand Medical Technologies IPO covers bidding day 3, with overall subscription closing at 14.21×; the strongest category was qualified institutional buyers (QIB) at 34.7×.

Category detail

The QIB portion ended at 34.7×. Non-institutional investors came in at 14.64×. Retail investors put in bids for 3.04× the shares reserved for them. That puts qualified institutional buyers (QIB) at the top of the book at 34.7× and retail investors at the bottom at 3.04×.

What the multiple means for allotment

Retail bids ran to about 3.04 times the shares earmarked for the category. When a retail book is oversubscribed, the registrar does not allot proportionately — allotment runs as a computerised lottery among all valid applications, with each successful application receiving at least one lot of 43 shares — ₹14,792 of stock at the upper band. The multiple above is the data point that determines how thinly that draw is spread; it describes the final book, not the outcome of any single application.

Frequently asked questions

When does the Sahajanand Medical Technologies IPO open and close?
The Sahajanand Medical Technologies IPO opens on 15 Oct 2026 and closes on 19 Oct 2026.
How many times was the Sahajanand Medical Technologies IPO subscribed?
The Sahajanand Medical Technologies IPO was subscribed 14.21 times in total across all investor categories.
What is the reservation split in the Sahajanand Medical Technologies IPO?
Of the total shares offered, retail investors get 34.37%, QIBs 19.64% (plus 29.46% anchor), non-institutional investors 14.73%.